Evidence map›Paper›PMID 37509652›Full record

ArticleBiomedicines2023

The Role of the

Rebecca V Steenaard, Richard A Feelders, Fadime Dogan, Peter M van Koetsveld, Sara G Creemers, Madeleine H T Ettaieb, Folkert J van Kemenade, Harm R Haak, Leo J Hofland

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Rebecca V SteenaardDepartment of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands.
Richard A FeeldersDepartment of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands.
Fadime DoganDepartment of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands.
Peter M van KoetsveldDepartment of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands.
Sara G CreemersDepartment of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands.
Madeleine H T EttaiebDepartment of Internal Medicine, Tergooi MC, 1213 XZ Hilversum, The Netherlands.
Folkert J van KemenadeDepartment of Pathology, Erasmus Medical Center, 3015 CA Rotterdam, The Netherlands.ORCID 0000-0002-4225-4354
Harm R HaakDepartment of Internal Medicine, Máxima MC, 5504 DB Veldhoven, The Netherlands.ORCID 0000-0001-7385-9359
Leo J HoflandDepartment of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands.
Erasmus MC · NLRadboud University Nijmegen · NLTergooi · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The differentiation between benign and malignant adrenocortical tumors based on pathological assessment can be difficult. We present a series of 17 patients with unclear malignant tumors, of whom six had recurrent or metastatic disease. The assessment of the methylation pattern of insulin-like growth factor 2 (

Indexed as

adrenocortical adenomaadrenocortical carcinomaformalin-fixed paraffin-embedded tissueIGF2methylation

Identifiers

PMID37509652
PMCPMC10377429
OpenAlexW4384695142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.